Literature DB >> 1638760

Experimental autoimmune uveoretinitis (EAU) versus experimental allergic encephalomyelitis (EAE): a comparison of T cell-mediated mechanisms.

V L Calder1, S L Lightman.   

Abstract

EAU is a model of ocular inflammatory disease. EAU resembles another T cell-mediated autoimmune disease--experimental allergic encephalomyelitis--since both have increased expression of MHC class II molecules in the target tissue, can be adoptively transferred by activated CD4+ T cells and are inhibited by cyclosporin A. The immunological findings will be compared to find out if the same cellular mechanisms are involved in both diseases.

Entities:  

Mesh:

Year:  1992        PMID: 1638760      PMCID: PMC1554436          DOI: 10.1111/j.1365-2249.1992.tb06926.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  60 in total

1.  Randomised double blind controlled trial of cyclosporin in multiple sclerosis.

Authors:  P Rudge; J C Koetsier; J Mertin; J O Mispelblom Beyer; H K Van Walbeek; R Clifford Jones; J Harrison; K Robinson; B Mellein; T Poole
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-05       Impact factor: 10.154

2.  Inhibition of experimental autoimmune encephalomyelitis induction in SJL/J mice by using a peptide with high affinity for IAs molecules.

Authors:  A G Lamont; A Sette; R Fujinami; S M Colón; C Miles; H M Grey
Journal:  J Immunol       Date:  1990-09-15       Impact factor: 5.422

3.  Identification of transforming growth factor-beta as an immunosuppressive factor in aqueous humor.

Authors:  S W Cousins; M M McCabe; D Danielpour; J W Streilein
Journal:  Invest Ophthalmol Vis Sci       Date:  1991-07       Impact factor: 4.799

4.  Cyclosporine-induced specific unresponsiveness to retinal soluble antigen in experimental autoimmune uveoretinitis.

Authors:  Y Fujino; A Okumura; R B Nussenblatt; I Gery; M Mochizuki
Journal:  Clin Immunol Immunopathol       Date:  1988-02

5.  Experimental allergic uveitis. Isolation, characterization, and localization of a soluble uveitopathogenic antigen from bovine retina.

Authors:  W B Wacker; L A Donoso; C M Kalsow; J A Yankeelov; D T Organisciak
Journal:  J Immunol       Date:  1977-12       Impact factor: 5.422

6.  Activated T lymphocytes produce a matrix-degrading heparan sulphate endoglycosidase.

Authors:  Y Naparstek; I R Cohen; Z Fuks; I Vlodavsky
Journal:  Nature       Date:  1984 Jul 19-25       Impact factor: 49.962

7.  Prevention of experimental allergic encephalitis with in vivo administration of anti I-A antibody. Decreased accumulation of radiolabelled lymph node cells in the central nervous system.

Authors:  L Steinman; D Solomon; M Lim; S Zamvil; S Sriram
Journal:  J Neuroimmunol       Date:  1983-08       Impact factor: 3.478

8.  Fc receptor density, MHC antigen expression and superoxide production are increased in interferon-gamma-treated microglia isolated from adult rat brain.

Authors:  M N Woodroofe; G M Hayes; M L Cuzner
Journal:  Immunology       Date:  1989-11       Impact factor: 7.397

9.  Controlled trial of faecal occult blood testing in the detection of colorectal cancer.

Authors:  J D Hardcastle; P A Farrands; T W Balfour; J Chamberlain; S S Amar; M G Sheldon
Journal:  Lancet       Date:  1983-07-02       Impact factor: 79.321

10.  Adoptive transfer of EAE-like lesions from rats with coronavirus-induced demyelinating encephalomyelitis.

Authors:  R Watanabe; H Wege; V ter Meulen
Journal:  Nature       Date:  1983 Sep 8-14       Impact factor: 49.962

View more
  6 in total

1.  Suppression of actively induced experimental autoimmune uveoretinitis by CD4+ T cells.

Authors:  E Uchio; M Kijima; M Ishioka; S Tanaka; S Ohno
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-02       Impact factor: 3.117

2.  Dual Function of the IRF8 Transcription Factor in Autoimmune Uveitis: Loss of IRF8 in T Cells Exacerbates Uveitis, Whereas Irf8 Deletion in the Retina Confers Protection.

Authors:  Sung-Hye Kim; Jenna Burton; Cheng-Rong Yu; Lin Sun; Chang He; Hongsheng Wang; Herbert C Morse; Charles E Egwuagu
Journal:  J Immunol       Date:  2015-07-10       Impact factor: 5.422

3.  MHC class II expression and potential antigen-presenting cells in the retina during experimental autoimmune uveitis.

Authors:  Deborah A Lipski; Rémi Dewispelaere; Vincent Foucart; Laure E Caspers; Matthieu Defrance; Catherine Bruyns; François Willermain
Journal:  J Neuroinflammation       Date:  2017-07-18       Impact factor: 8.322

4.  Loss of STAT3 in CD4+ T cells prevents development of experimental autoimmune diseases.

Authors:  Xuebin Liu; Yun Sang Lee; Cheng-Rong Yu; Charles E Egwuagu
Journal:  J Immunol       Date:  2008-05-01       Impact factor: 5.422

5.  Multicellular immune dynamics implicate PIM1 as a potential therapeutic target for uveitis.

Authors:  He Li; Lihui Xie; Lei Zhu; Zhaohuai Li; Rong Wang; Xiuxing Liu; Zhaohao Huang; Binyao Chen; Yuehan Gao; Lai Wei; Chang He; Rong Ju; Yizhi Liu; Xialin Liu; Yingfeng Zheng; Wenru Su
Journal:  Nat Commun       Date:  2022-10-04       Impact factor: 17.694

6.  An autoimmune disease with multiple molecular targets abrogated by the transgenic expression of a single autoantigen in the thymus.

Authors:  F Alderuccio; B H Toh; S S Tan; P A Gleeson; I R van Driel
Journal:  J Exp Med       Date:  1993-08-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.